Healthcare provider profile · identity verified

Sara Loetscher, MD

Family Practice · DUBUQUE, IA · NPI 1124112503

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	695	135
Atorvastatin Calcium	Atorvastatin Calcium	660	168
Losartan Potassium	Losartan Potassium	501	107
Amlodipine Besylate	Amlodipine Besylate	492	117
Omeprazole	Omeprazole	458	101
Lisinopril	Lisinopril	379	88
Gabapentin	Gabapentin	378	70
Potassium Chloride	Potassium Chloride	351	77
Furosemide	Furosemide	345	82
Tramadol Hcl	Tramadol Hcl	297	62
Simvastatin	Simvastatin	273	70
Metoprolol Succinate	Metoprolol Succinate	244	54
Sertraline Hcl	Sertraline Hcl	237	54
Trazodone Hcl	Trazodone Hcl	216	39
Allopurinol	Allopurinol	194	43
Metoprolol Tartrate	Metoprolol Tartrate	192	38
Lorazepam	Lorazepam	184	39
Hydrochlorothiazide	Hydrochlorothiazide	183	48
Cephalexin	Cephalexin	181	76
Pantoprazole Sodium	Pantoprazole Sodium	169	39
Atenolol	Atenolol	152	31
Glimepiride	Glimepiride	150	38
Mirtazapine	Mirtazapine	149	26
Donepezil Hcl	Donepezil Hcl	123	18
Pravastatin Sodium	Pravastatin Sodium	123	24
Prednisone	Prednisone	123	66
Alendronate Sodium	Alendronate Sodium	120	31
Ropinirole Hcl	Ropinirole Hcl	117	15
Alprazolam	Alprazolam	114	22
Clopidogrel	Clopidogrel Bisulfate	113	23
Eliquis	Apixaban	113	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	21
Spironolactone	Spironolactone	107	24
Clonazepam	Clonazepam	99	15
Metformin Hcl Er	Metformin Hcl	99	26
Metformin Hcl	Metformin Hcl	98	19
Meloxicam	Meloxicam	85	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	83	23
Memantine Hcl	Memantine Hcl	82	12
Baclofen	Baclofen	81	13
Duloxetine Hcl	Duloxetine Hcl	76	11
Citalopram Hbr	Citalopram Hydrobromide	75	15
Rosuvastatin Calcium	Rosuvastatin Calcium	74	18
Tamsulosin Hcl	Tamsulosin Hcl	69	17
Quetiapine Fumarate	Quetiapine Fumarate	68	11
Propranolol Hcl	Propranolol Hcl	67	14
Zolpidem Tartrate	Zolpidem Tartrate	66	suppressed
Xarelto	Rivaroxaban	65	suppressed
Warfarin Sodium	Warfarin Sodium	64	11
Enalapril Maleate	Enalapril Maleate	61	13
Fluticasone Propionate	Fluticasone Propionate	61	22
Risperidone	Risperidone	61	suppressed
Sucralfate	Sucralfate	59	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	15
Ipratropium Bromide	Ipratropium Bromide	52	12
Nystatin	Nystatin	51	29
Doxycycline Hyclate	Doxycycline Hyclate	50	28
Lovastatin	Lovastatin	50	12
Pregabalin	Pregabalin	48	suppressed
Celecoxib	Celecoxib	47	suppressed
Levetiracetam	Levetiracetam	47	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	46	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	46	39
Albuterol Sulfate Hfa	Albuterol Sulfate	45	21
Chlorthalidone	Chlorthalidone	43	13
Triamcinolone Acetonide	Triamcinolone Acetonide	43	18
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Temazepam	Temazepam	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Fentanyl	Fentanyl	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	13
Acyclovir	Acyclovir	38	13
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Clonidine Hcl	Clonidine Hcl	37	suppressed
Famotidine	Famotidine	37	13
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Trintellix	Vortioxetine Hydrobromide	36	suppressed
Estradiol	Estradiol	33	16
Azithromycin	Azithromycin	32	29
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	16
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	12
Benazepril Hcl	Benazepril Hcl	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Labetalol Hcl	Labetalol Hcl	28	suppressed
Nystop	Nystatin	27	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Glipizide	Glipizide	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	19
Ezetimibe	Ezetimibe	25	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Olanzapine	Olanzapine	24	suppressed
Cefdinir	Cefdinir	23	16
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Carvedilol	Carvedilol	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Fluconazole	Fluconazole	20	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	11
Primidone	Primidone	19	suppressed
Amoxicillin	Amoxicillin	18	12
Flecainide Acetate	Flecainide Acetate	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Haloperidol	Haloperidol	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Ozempic	Semaglutide	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Nyamyc	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Clonidine	Clonidine	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	13	12
Tri-Sprintec	Norgestimate-Ethinyl Estradiol	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Ramipril	Ramipril	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Diazepam	Diazepam	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error